New study on ILK function in CLL published in Cancer Research

February 5, 2016

The Hartmann Lab in collaboration with CCS colleagues Richard Greil, Alexander Egle, Fritz Aberger and Daniel Neureiter published new data on the role of Integrin-Linked Kinase in Chronic Lymphocytic Leukemia (CLL). The findings identify a critical role of ILK in CLL development in response to TNFa-NFkB signaling. The study has been published on Feb 2 2016 in Cancer Research ahead of print. For details see Krenn et al., 2016. Cancer Res. 

Please reload

 Recommended News 

Salzburg Breast Cancer Meeting - Mastering Translational Immuno-Oncology

January 13, 2017

Please reload

 Recent News 
Please reload